Company Filing History:
Years Active: 1993-2001
Title: The Innovations of John J. Grome
Introduction
John J. Grome is a notable inventor based in Wiesbaden, Germany, with a commendable portfolio of seven patents. His work primarily focuses on advancements in the field of pharmaceuticals, particularly related to xanthine compounds and their applications in treating critical health conditions.
Latest Patents
Among his most recent patents, Grome has made significant contributions with the following innovations:
1. **Use of theophylline derivatives for the treatment and prophylaxis of states of shock** - This patent involves novel xanthine compounds and the processes for their preparation. Specifically, it addresses theophylline derivatives that include at least one ether function modified in the 1-position of the methyl radical that are useful for treating and preventing states of shock.
2. **Xanthine compounds having terminally animated alkynol side chains** - This patent describes compounds with neuroprotective effects, characterized by specific alkynol residues suitable for pharmaceutical applications.
Career Highlights
John J. Grome has established a successful career at Hoechst Aktiengesellschaft, contributing significantly to pharmaceutical development. His commitment to innovation and research has helped pave the way for new treatments through the discovery of vital compounds and their therapeutic applications.
Collaborations
During his career, Grome has collaborated with esteemed coworkers, including Ulrich Gebert and Karl Rudolphi. Together, they have worked on various projects that blend their expertise in chemistry and pharmacology, further enhancing the impact of their inventions in the industry.
Conclusion
John J. Grome's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts showcase the importance of research and development in creating effective treatment solutions. His work not only reflects his dedication as an inventor but also underlines the potential of xanthine derivatives in medical advancements.